Govt's Health­care & S& T poli­cies for­ward look­ing: in­dus­try

In­dus­try looks for more

BioSpectrum (India) - - FRONT PAGE -

Pub­lic health is still evolv­ing in In­dia and is wit­ness­ing many hur­dles in its at­tempt to­wards bet­ter health­care fa­cil­i­ties. The Modi govern­ment is fo­cus­ing on health­care re­forms and is mov­ing to­wards qual­ity free health­care. This in­cludes E-Health scheme, free health­care schemes for the un­af­ford­ing and health­care ser­vices in the in­ac­ces­si­ble ar­eas.

The govern­ment’s ini­tia­tive of Make in In­dia, is work­ing in sync with the med­i­cal equip­ment in­dus­try and boost­ing its growth. This has led to an in­crease in the do­mes­tic man­u­fac­tur­ing of med­i­cal equip­ment and sim­u­la­tors. The in­crease in out­lay for health­care sec­tor in the last bud­get is a step ahead to achieve all of the above. Some of the state gov­ern­ments are also aug­ment­ing the above men­tioned steps.

The an­nounce­ment of many scheme in­clud­ing that of “Ayush­maan Bharat Scheme” by the Modi govern­ment of­fers both op­por­tu­nity and re­spon­si­bil­ity for the life sciences in­dus­try. The in­dus­try looks for more sup­port from the govern­ment in terms of fund­ing, em­pha­sis on Trans­la­tional & Ap­plied Sci­ence and higher ed­u­ca­tion.

“The Modi govern­ment is fo­cus­ing on health­care. So changes come in and they should be wel­comed. All changes are as­so­ci­ated with an in­er­tia to change. There is no ques­tion that this brings in prob­lems for the ex­ist­ing health­care sys­tems. It would be the prime re­spon­si­bil­ity of the health­care sys­tem to adapt as fast as pos­si­ble to the changes. At the same time it is the re­spon­si­bil­ity of the govern­ment to push things at an ac­cept­able pace,” says Dr Ashish Rawan­dale, MD, Te­j­naksh Health­care.

Pa­van Choudary, MD, Vy­gon In­dia says “There is no am­bi­gu­ity that this govern­ment has in­tro­duced some much re­quired and in­no­va­tive schemes for the wel­fare of the pub­lic; how­ever as re­spon­si­ble ci­ti­zens, we must also alert the govern­ment, time and again to­wards adapt­ing a more nu­anced and struc­tured im­ple­men­ta­tion plan for these schemes and urge them to con­sider the rec­om­men­da­tions of all the stake­hold­ers from the health­care in­dus­try.”

“The govern­ment should im­ple­ment the Na­tional Med­i­cal De­vice Pol­icy with a sense of ur­gency” says Vishnu Bhat, Founder & Chair­man, Blue Neem Med­i­cal De­vices and adds “Its im­ple­men­ta­tion will help the lo­cal in­dus­try blos­som with im­mense ben­e­fits to pa­tients. De­velop clear long term vi­sion and road map for the med­i­cal de­vices in­dus­try, along­side phar­ma­ceu­ti­cal and health cen­ters to ad­dress the health care in­dus­try holis­ti­cally.”

Ac­cord­ing to Dr San­jay Sarin, Head of FIND In­dia, the chal­lenges in­clude im­prov­ing link­ages to se­condary and ter­tiary health­care lev­els, short­age of skilled health­care work­ers at all lev­els from doc­tors to paramed­i­cal work­ers, health­care fi­nanc­ing, im­prove ac­cess at pri­mary health­care lev­els and im­prove qual­ity of health­care de­liv­ery.

“What is needed to­day is to bridge this widen­ing trust gap be­tween the pri­vate health­care providers and oth­ers. It is crit­i­cal that all the stake­hold­ers ad­dress the is­sue of trust deficit as a pri­or­ity, work­ing in col­lab­o­ra­tion with each other,” says (Hony.) Brig Dr Arvind Lal, CMD, Dr Lal PathLabs

Shar­ing his views on the chal­lenges, De­bayan Ghosh – Pres­i­dent & Founder, Epy­gen Biotech says “Though se­lected states take proac­tive role in the na­tional biotech progress, it is ex­pected that the fed­eral govern­ment shall in­cen­tivize all the states of the coun­try to join in this jour­ney of the sun­rise in­dus­try!”

Com­ment­ing on the need for in­fra­struc­ture de­vel­op­ment Dr Tasli­marif Saiyed, CEO & Di­rec­tor, C-CAMP says “There is a need to have a ma­jor Life Sci­ence Re­search Park near cur­rent in­no­va­tion hubs like C-CAMP so that some of these small start-ups can grow but still re­main in in­no­va­tion clus­ter.”

On is­sues be­fore the in­dus­try which need at­ten­tion from the govern­ment, Murli Sun­drani, Busi­ness Di­rec­tor, BD Life sciences- bio­sciences says “Our ex­pec­ta­tion is to in­crease the pie of R&D fund­ing so that both ba­sic and so­cio-eco­nomic re­search con­tin­ues and com­ple­ment each other.”

In the com­ing pages we are cov­er­ing ex­perts’ opin­ion on dif­fer­ent as­pects of life sciences in­dus­try from in­no­va­tion to IoT, bi­o­log­i­cals to dig­i­tal tech­nolo­gies, and biotech­nol­ogy to med­i­cal de­vices.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.